Sep 8th, 2025
The event ProteostaSys: a systems view of proteostasis took place at Hilton Cambridge City Centre in Cambridge, UK. Ronald Melki attended with the talk “Proteostasys in alpha-synuclein & tau aggregates polymorphism and the structural molecular basis of diverse synucleinopathies and tauopathies“.
Aug 29th, 2025
The AMED Proteostasis in Biology and Medicine International Symposium was held between Aug 26th and 29th at The Prince Kyoto Takaragaike in Kyoto, Japan. Ronald Melki attended with the talk “Alpha-synuclein aggregates polymorphism and the structural molecular basis of diverse synucleinopathies, role of proteostasis“.
June 9th
The 10th Mediterranean Neuroscience Society Conference was held between June 7th and 10th at Minoa Palace Resort in Chania, Greece. Ronald Melki attended with the talk “Alpha-synuclein and tau aggregates polymorphism in distinct synucleinopathies and taupathies“.
May 20th, 2025
The EMBO workshop Protein quality control: From molecular mechanisms to aging and disease was held May 18th to 23rd in Hersonissos, Greece . Ronald Melki attended with the talk “Alpha-synuclein and tau aggregates polymorphism and the structural molecular basis of diverse synucleinopathies and taupathies“.
May 13th-14th, 2025
The annual ERA PerMed – DEEPEN iRBD consortium meeting was held in Saint Rémy-Lès-Chevreuse in the outskirts of Paris. Statuses on the different work packages were given and scientific obstacles discussed in the beautiful surroundings of Domaine de Saint-Paul.
April 8th-11th, 2025
The 2025 edition of the Synuclein meeting was held in Cambridge (UK) at the West Road Concert Hall. Ronald Melki attended with the talk “Alpha-synuclein aggregates polymorphism and the structural molecular basis of distinct synucleinopathies” and Céline Galvagnion with the talk “Lipidomic profiling reveals shared and distinct pathological signatures in sporadic Parkinson’s Disease and GBA mutation carriers”.
April 2nd-5th, 2025
The annual ESC congress of Preventive Cardiology was held in Milan and was attended by Clara Gino and Beatrice De Maria.
“We had the opportunity to present a poster with preliminary results from the systematic review with meta-analysis we conducted to investigate the differences between iRBD and the control group, evaluating heart rate variability (HRV) analysis. Pointed results highlited the advantage in phasing HRV analysys with sleep stages, confirming the importance of a multi-perspective approach.“
February 11th-13th, 2025
EP PerMed conference on Personalised Medicine Research and Training on Scientific Integrity in Berlin was attended by Serena Covino and Clara Gino. The conference was an opportunity to hear about personalised medicine projects in different fields, and to learn about the project referred to by DEEPEN iRBD from a broader perspective.
As part of the conference a workshop was provided. The focus of the workshop was to exchange with other young researchers and give a moment to discuss vertical issues affecting the field of medical and scientific research, regarding ethical and good practice aspects.
November 16th, 2024
Presentation given to the Main Board of The Danish Parkinson’s Association by Céline Galvagnion of the DEEPEN-iRBD project. The presentation was followed up by questions and dialogue.
August 22nd, 2024:
Presentation given at the 36th European Conference on Philosophy of Medicine and Health Care in Offenbach, by Ana Borovečki. Presentation was titled “Personalised communication: The right message for the right patient at the right time“.
July 16th, 2024:
Presentation given at the International Conference From preclinical to clinical PD – Biological classification and translation to precision medicine, by Ana Borovečki. Presentation was titled “Risk Disclosure” and was given on behalf of the Work Package 5 group.
DEEPEN-iRBD 